View More Recent Stories

Apr 8, 2019 07:35AM UPDATE: Translate Bio, Inc. (TBIO) Appoints Richard Wooster as Chief Scientific Officer
Apr 8, 2019 07:30AM Translate Bio Appoints Richard Wooster as Chief Scientific Officer
Apr 8, 2019 07:30AM Translate Bio Appoints Richard Wooster as Chief Scientific Officer
Apr 1, 2019 07:30AM Translate Bio Appoints Pasquale (Pat) Sacco as Senior Vice President of Technical Operations
Apr 1, 2019 07:30AM Translate Bio Appoints Pasquale (Pat) Sacco as Senior Vice President of Technical Operations
Mar 26, 2019 07:30AM Translate Bio Granted U.S. Patent Relating to Messenger RNA (mRNA) Delivery
Mar 26, 2019 07:30AM Translate Bio Granted U.S. Patent Relating to Messenger RNA (mRNA) Delivery
Mar 25, 2019 07:30AM Translate Bio to Participate in Upcoming Investor Conferences
Mar 25, 2019 07:30AM Translate Bio to Participate in Upcoming Investor Conferences
Mar 21, 2019 04:29PM Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights
Mar 21, 2019 04:29PM Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights
Mar 18, 2019 07:35AM Translate Bio (TBIO) Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model
Mar 18, 2019 07:30AM Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model in the Journal Molecular Therapy
Mar 18, 2019 07:30AM Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model in the Journal Molecular Therapy
Mar 4, 2019 07:30AM Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
Mar 4, 2019 07:30AM Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
Feb 27, 2019 04:30PM Translate Bio Provides Updates on Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency Programs
Feb 27, 2019 04:30PM Translate Bio Provides Updates on Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency Programs
Feb 14, 2019 07:30AM Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
Feb 14, 2019 07:30AM Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
Jan 22, 2019 07:35AM Translate Bio (TBIO) Announces FDA Clinical Hold on IND for MRT5201 for Treatment of OTC Deficiency
Jan 22, 2019 07:30AM Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
Jan 22, 2019 07:30AM Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
Jan 3, 2019 07:46AM Translate Bio (TBIO) Granted Approval to Begin Multiple-Ascending DOse in Phase 1/2 Clinical Trial of MRT5005
Jan 3, 2019 07:34AM Translate Bio (TBIO) Announces Robert Meyer MD to Board
Jan 3, 2019 07:30AM Translate Bio Appoints Robert Meyer, MD, to its Board of Directors
Jan 3, 2019 07:30AM Translate Bio Advances Programs in Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency
Jan 3, 2019 07:30AM Translate Bio Appoints Robert Meyer, MD, to its Board of Directors
Jan 3, 2019 07:30AM Translate Bio Advances Programs in Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency
Dec 4, 2018 09:15AM Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)
Dec 4, 2018 09:15AM Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)
Nov 8, 2018 04:21PM Translate Bio Announces Third Quarter 2018 Financial Results and Reviews Recent Highlights
Nov 8, 2018 04:21PM Translate Bio Announces Third Quarter 2018 Financial Results and Reviews Recent Highlights
Nov 1, 2018 07:30AM Translate Bio to Participate in Upcoming Investor Conferences
Nov 1, 2018 07:30AM Translate Bio to Participate in Upcoming Investor Conferences
Oct 18, 2018 07:30AM Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference
Oct 18, 2018 07:30AM Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference
Sep 25, 2018 07:30AM Translate Bio to Participate in the Leerink Partners Roundtable Series: Rare Disease & Oncology
Sep 25, 2018 07:30AM Translate Bio to Participate in the Leerink Partners Roundtable Series: Rare Disease & Oncology
Aug 30, 2018 07:30AM Translate Bio to Participate in Citi’s 13th Annual Biotech Conference
Aug 30, 2018 07:30AM Translate Bio to Participate in Citi’s 13th Annual Biotech Conference
Aug 9, 2018 04:17PM Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements 
Aug 9, 2018 04:17PM Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements 
Jul 9, 2018 07:00AM Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases
Jul 9, 2018 07:00AM Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases
View More Recent Stories